No takes yet. Share an insight, caveat, or question.
Examines ESG disclosure's role in firm performance, implying a complex interaction with governance mechanisms.
Tahtamoni et al. (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: